We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Study in Adult and Adolescent Subjects With PAR

- Rhinitis, Female, Maleergic, Perennial
- Completed

Study Title: Study in Adult and Adolescent Subjects With PAR (Perennial Female, Maleergic Rhinitis)

Teva Identifier: BDP-AR-302

ClinicalTrials.gov Identifier: NCT01134705

Study Status: Completed

Trial Condition(s): Rhinitis, Female, Maleergic, Perennial

Interventions: Drug: Beclomethasone dipropionate hydrofluoroalkane HFA Nasal Aerosol | Drug: Placebo Nasal Aerosol

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age Range: 12 Years and older

Trial Duration: 05/01/2010 - 10/01/2010

Phase: Phase 3

Study Type

Interventional